The effect of Eugenia Caryophillat,s product on depressio
Phase 3
- Conditions
- Condition 1: Major depressive disorder, single episode, moderate. Condition 2: Major depressive disorder, single episode, mild.Major depressive disorder, single episode, moderateMajor depressive disorder, single episode, mildF32.1F32.0
- Registration Number
- IRCT20190309042979N1
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1-Declaration of written consent of the candidate for participation
18-65 years old
Detection of major depressive disorder based on DSM-5 and treated for more than 6 weeks
Score 14 to 28 in the depression test 21 BDI-II questions
Exclusion Criteria
symptoms of high mood
suicide incidence
The incidence of unknown side effect
patient request
pregnancy and lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression Score. Timepoint: Before the start of the intervention (week 0) and 14, 28 and 42 days after the start of the intervention. Method of measurement: Beck questionnaire.
- Secondary Outcome Measures
Name Time Method